PROCEPT BioRobotics (PRCT) Cash from Operations (QoQ) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | PROCEPT BioRobotics | 1.58 Bn | 1.33 Bn | 53.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -269.20% |
| Dec 31, 2025 | -55.64% |
| Sep 30, 2025 | 55.89% |
| Jun 30, 2025 | 11.41% |
| Mar 31, 2025 | 47.58% |
| Dec 31, 2024 | -72.29% |
| Sep 30, 2024 | -19.47% |
| Jun 30, 2024 | 51.26% |
| Mar 31, 2024 | -30.22% |
| Dec 31, 2023 | -30.88% |
| Sep 30, 2023 | 33.16% |
| Jun 30, 2023 | 21.12% |
| Mar 31, 2023 | -42.72% |
| Dec 31, 2022 | -26.81% |
| Sep 30, 2022 | -15.91% |
| Jun 30, 2022 | 6.06% |
| Mar 31, 2022 | -10.65% |
| Dec 31, 2021 | -29.21% |
| Sep 30, 2021 | 1.22% |
| Jun 30, 2021 | 15.06% |
| Mar 31, 2021 | -13.04% |